Dr.MRIDULA RANJAN

Dr. RAMYASH SINGH YADAV, Dr. RAM KUMAR JAISWAL

Abstract

Introduction- Diabetic Macular Edema is an important cause of visual impairment,caused by increased vascular permeability leading to fluid accumulation & retinal haemorrhages in the macula.Aim & objective- comparison of effect of intravitreal injection Ranibizumab and Triamcinolone Acetonide in Diabetic Macular Edema. Method & material- in our study 42 patients with Diabetic Macular Edema divided into two groups, received Ranibizumab (0.5mg in 0.05ml) in one group & Triamcinolone (4mg in 0.1ml) in other group. Results- central macular thickness (CMT) is observed with OCT before injection and at 2week,4week after Injection in both groups. Conclusion-Both treatment types had good effect on reduction of central macular thickness & improvement of BCVA with consideration that Triamcinolone treated group showed significantly lower CMT compared to Ranibizumab treated group.